Breaking News Instant updates and real-time market news.

SRPT

Sarepta

$29.41

1 (3.52%)

14:46
04/13/17
04/13
14:46
04/13/17
14:46

Sarepta call volume above normal and directionally bullish

Bullish option flow detected in Sarepta with 2,748 calls trading, 1.3x expected, and implied vol increasing almost 4 points to 76.89%. 4/13 weekly 29.5 calls and Apr-17 30 calls are the most active options, with total volume in those strikes near 1,700 contracts. The Put/Call Ratio is 0.21. Earnings are expected on May 4th.

SRPT Sarepta
$29.41

1 (3.52%)

03/10/17
JPMS
03/10/17
NO CHANGE
Target $42
JPMS
Overweight
JPMorgan raises Sarepta price target after payers survey
JPMorgan analyst Anupam Rama raised his price target for Sarepta Therapeutics to $42 from $40 after conducting a "quick" survey of U.S. based payers. The stock closed yesterday down 70c to $32.73. The results indicate broad and early coverage of Sarepta's Duchene Muscular Dystrophy treatment Exondys 51, Rama tells investors in a research note. Further, the survey shows rapid time from patient start form submission to authorized drug reimbursement, and a steady increase in patient adds over the next 12 months, the analyst adds. The results also made clear, however, that increased disease education is needed at the payer level. The analyst is "very encouraged" by the survey results and increased his 2017 Exondys 51 sales estimate to $94M, above the $90M-$91M consensus. He reiterates an Overweight rating on Sarepta.
03/10/17
COWN
03/10/17
NO CHANGE
Target $62
COWN
Outperform
Cowen sees coverage re-evaluations as positive for Sarepta
Cowen analyst Ritu Baral believes payors are still actively evaluating and re-evaluating coverage of Sarepta Therapeutics' Exondys 51. It appears that Anthem (ANTM), after an initial denial of coverage, has re-evaluated its decision on Exondys, Baral tells investors in a research note. She notes, though, that coverage discussions appear to be ongoing and amenable patients are still experiencing denials. The analyst sees the re-evaluations of coverage as positive for Sarepta. Baral has an Outperform rating on the shares with a $62 price target.
03/27/17
OPCO
03/27/17
NO CHANGE
Target $76
OPCO
Outperform
Oppenheimer remains bullish on Sarepta
Oppenheimer analyst Hartaj Singh remains bullish on Sarepta after the company presented long-term data on the potential benefits of Exondys 51 on cardiac and pulmonary function. The analyst notes that while clinical trial data for patients on drug for less than one year is "not very compelling," long-term data on cardiac and pulmonary complications demonstrates the drug slowing progression. It is this data that has created a positive buzz among the Duchenne Muscular Dystrophy community and is key in the European application, he argues. Singh reiterates an Outperform rating and $76 price target on the shares.
04/05/17
RHCO
04/05/17
UPGRADE
Target $45
RHCO
Buy
Sarepta upgraded to Buy from Hold at SunTrust
SunTrust analyst Edward Nash upgraded Sarepta to Buy from Hold and maintained a $45 price target. Nash told investors the long-term cardiac and pulmonary function data presented at the MDA Scientific Conference could provide further support for Exondys 51 market adoption and payer coverage.

TODAY'S FREE FLY STORIES

GE

General Electric

$17.83

-0.15 (-0.83%)

, DKS

Dick's Sporting

$28.58

-0.52 (-1.79%)

07:30
11/22/17
11/22
07:30
11/22/17
07:30
Options
Unusual put flow in option market yesterday »

Notable put activity was…

GE

General Electric

$17.83

-0.15 (-0.83%)

DKS

Dick's Sporting

$28.58

-0.52 (-1.79%)

ROST

Ross Stores

$72.67

-0.07 (-0.10%)

ILG

ILG

$28.11

-0.5 (-1.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

  • 30

    Nov

  • 01

    Dec

  • 12

    Dec

DLTR

Dollar Tree

$99.46

2.35 (2.42%)

07:29
11/22/17
11/22
07:29
11/22/17
07:29
Recommendations
Dollar Tree analyst commentary  »

Dollar Tree price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:28
11/22/17
11/22
07:28
11/22/17
07:28
General news
Futures above fair value ahead of holiday »

Stock futures are…

SHOO

Steven Madden

$39.80

-0.6 (-1.49%)

07:28
11/22/17
11/22
07:28
11/22/17
07:28
Conference/Events
Steven Madden management to meet with Buckingham »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

BURL

Burlington Stores

$104.94

-1.61 (-1.51%)

07:25
11/22/17
11/22
07:25
11/22/17
07:25
Recommendations
Burlington Stores analyst commentary  »

Burlington Stores price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RLH

Red Lion Hotels

$8.55

0.1 (1.18%)

07:24
11/22/17
11/22
07:24
11/22/17
07:24
Conference/Events
Red Lion Hotels management to meet with Craig Hallum »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 30

    Nov

  • 06

    Dec

TIVO

TiVo

$17.65

0.15 (0.86%)

, CMCSA

Comcast

$36.42

0.59 (1.65%)

07:24
11/22/17
11/22
07:24
11/22/17
07:24
Recommendations
TiVo, Comcast, Comcast analyst commentary  »

TiVo ITC win raises odds…

TIVO

TiVo

$17.65

0.15 (0.86%)

CMCSA

Comcast

$36.42

0.59 (1.65%)

CMCSK

Comcast

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADBE

Adobe

$184.15

1.81 (0.99%)

07:22
11/22/17
11/22
07:22
11/22/17
07:22
Recommendations
Adobe analyst commentary  »

Adobe price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PSTI

Pluristem

$1.51

0.05 (3.42%)

07:20
11/22/17
11/22
07:20
11/22/17
07:20
Conference/Events
Pluristem management to meet with Seaport Global »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 29

    Nov

HRL

Hormel Foods

$34.52

1.12 (3.35%)

07:20
11/22/17
11/22
07:20
11/22/17
07:20
Recommendations
Hormel Foods analyst commentary  »

Hormel Foods 2018…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

07:20
11/22/17
11/22
07:20
11/22/17
07:20
General news
FX Update: The dollar has traded softer »

FX Update: The dollar has…

BAX

Baxter

$64.25

0.37 (0.58%)

07:19
11/22/17
11/22
07:19
11/22/17
07:19
Recommendations
Baxter analyst commentary  »

Baxter price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 05

    Dec

  • 14

    Dec

GME

GameStop

$16.73

0.29 (1.76%)

07:19
11/22/17
11/22
07:19
11/22/17
07:19
Recommendations
GameStop analyst commentary  »

GameStop price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PRTA

Prothena

$45.97

1.37 (3.07%)

07:19
11/22/17
11/22
07:19
11/22/17
07:19
Conference/Events
Prothena management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 28

    Nov

  • 29

    Nov

CRM

Salesforce

$108.80

1.43 (1.33%)

07:18
11/22/17
11/22
07:18
11/22/17
07:18
Recommendations
Salesforce analyst commentary  »

Salesforce price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

QADA

QAD Inc.

$39.95

1.75 (4.58%)

07:15
11/22/17
11/22
07:15
11/22/17
07:15
Recommendations
QAD Inc. analyst commentary  »

QAD Inc. price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UAA

Under Armour

$12.85

-0.59 (-4.39%)

, UA

Under Armour

$11.36

-0.71 (-5.88%)

07:13
11/22/17
11/22
07:13
11/22/17
07:13
Recommendations
Under Armour, Under Armour analyst commentary  »

Under Armour continued…

UAA

Under Armour

$12.85

-0.59 (-4.39%)

UA

Under Armour

$11.36

-0.71 (-5.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RRTS

Roadrunner

$8.15

0.16 (2.00%)

07:10
11/22/17
11/22
07:10
11/22/17
07:10
Hot Stocks
Roadrunner appoints James Staley as chairman of the board »

Roadrunner Transportation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RILY

B. Riley Financial

$18.60

0.55 (3.05%)

07:10
11/22/17
11/22
07:10
11/22/17
07:10
Syndicate
Breaking Syndicate news story on B. Riley Financial »

B. Riley Financial files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FDC

First Data

$16.77

0.15 (0.90%)

07:09
11/22/17
11/22
07:09
11/22/17
07:09
Hot Stocks
First Data, AccorHotels form strategic relationship »

First Data announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SBS

SABESP

$9.95

0.22 (2.26%)

07:08
11/22/17
11/22
07:08
11/22/17
07:08
Upgrade
SABESP rating change  »

SABESP upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WDR

Waddell & Reed

$19.20

0.38 (2.02%)

07:07
11/22/17
11/22
07:07
11/22/17
07:07
Hot Stocks
Waddell & Reed names Brent Bloss COO »

Waddell & Reed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OTEX

OpenText

$33.91

0.38 (1.13%)

07:07
11/22/17
11/22
07:07
11/22/17
07:07
Downgrade
OpenText rating change  »

OpenText downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PSTI

Pluristem

$1.51

0.05 (3.42%)

07:04
11/22/17
11/22
07:04
11/22/17
07:04
Hot Stocks
Pluristem granted key U.S. patent for skeletal muscle regeneration »

Pluristem Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 29

    Nov

ROK

Rockwell Automation

$193.02

-1.21 (-0.62%)

, EMR

Emerson

$60.35

0.09 (0.15%)

07:04
11/22/17
11/22
07:04
11/22/17
07:04
Hot Stocks
Rockwell Automation board unanimously rejects Emerson proposal »

Rockwell Automation (ROK)…

ROK

Rockwell Automation

$193.02

-1.21 (-0.62%)

EMR

Emerson

$60.35

0.09 (0.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.